In vitro culture and stimulation of human peripheral lymphocytes were employed to investigate the role of cellular immunity in Mycoplasma pneumoniae disease. Subjects with documented natural infections served as donors. The lymphocyte response to whole M. pneumoniae organisms was determined as incorporation of tritiated thymidine in a semimicro culture system. The range of cellular reactivity stimulated by specific antigen was within the range stimulated by phytohemagglutinin. The difference between responses of subjects with documented infection and serologically negative controls was highly significant. Specific reactivity of peripheral lymphocytes correlated closely with the presence of serum growthinhibiting antibodies, and both persisted for several years following infection. Serum complement-fixing titers correlated well with lymphocyte stimulability during the first year but antibody, as measured by this technique, tended to disappear in later convalescence. In light of previous studies, which revealed a lack of correlation between humoral antibodies and resistance to reinfection, these results suggest that immunity to M. pneumoniae infection is mediated by circulating small lymphocytes.
The role of cellular immunity in Mycoplasma pneumoniae disease is unknown although the pathogenesis of natural and experimental infections with this agent has been studied for several years (10) . The lack of correlation of the course of infection with the appearance of serum antibodies (12) , the enigma of the role of secretory antibodies to M. pneumoniae (2, 11, 14) , and the relative ineffectiveness of killed vaccines (14) suggest, by the process of exclusion, that cell-mediated immunity could be the most important component of the host immune response to this agent.
Certain observations in previous studies indicate that cellular immunity is stimulated by natural and experimental M. pneumoniae infection. The histology of the typical pneumonic lesion, consisting of peribronchial and perivascular lymphocytic infiltrates (9) , resembles the lesions of delayed hypersensitivity in other organ systems (32) . In the hamster, most of the cells composing the acute lesions of experimental disease contain immunoglobulins, but a definite population of immunoglobulin-negative lymphocytes is also present (15) . Furthermore, the pulmonary infiltrates produced by a challenge infection occur in an accelerated sequence (6) and are composed of immunoglobulin-negative small lymphoid cells (15) .
Since direct examination of lung pathology is restricted by the rarity of fatalities in this disease (11, 24) , in vitro techniques were sought for study of the cell-mediated response. Lymphocyte culture and stimulation with microbial antigens have been investigated in a variety of bacterial (20, 26) , fungal (25, 29, 33) , viral (27) (28) , and rickettsial (8) infections and in volunteers infected with M. pneumoniae (23) . In most of these reports lymphocyte transformation showed a positive correlation with infection and, where tested, with skin tests for delayed hypersensitivity. Although other in vitro tests of lymphocyte function more directly reflect cellular immunity, lymphocyte transformation was more adaptable for clinical studies and is the first step in the assessment of several lymphocyte factors (3) . This report is concerned with the stimulability of lymphocytes from peripheral blood of volunteers in whom natural M. pneumoniae infection was documented by microbiological and serological methods. The results provide evidence that circulating small lymphocytes remain reactive to M. pneumoniae for at least several years.
MATERIALS AND METHODS Study population. Volunteers were selected from ongoing studies of acute respiratory disease in this laboratory. Three groups provided subjects: patients admitted to the University of North Carolina Student Infirmary with atypical pneumonia, faculty and 552 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from personnel of the Division of Health Affairs, and pediatric patients admitted to N.C. Memorial Hospital. Etiological agents were isolated from throat swabs and identified by methods previously described (7) .
Antigens for in vitro lymphocyte stimulation. M. pneumoniiae strain PI 104166 (12) was grown on a HeLa cell culture in Eagle's minimal essential medium supplemented with 10% horse serum and 2,000 units of penicillin G per ml. The culture was passed three times to eliminate nonreplicating products in the original seed material. The infected tissue cultures were scraped with a rubber spatula into fresh culture medium and frozen at -70 C in l-ml samples. Uninfected HeLa cultures were similarly processed as antigen controls. Quantitation of thawed samples of the antigen pool yielded 4 X 106 colony-forming units of M. pneumoniae per ml. Both antigen and control vials were heated at 56 C for 30 min prior to use. Antigen dilutions, tested in several preliminary lymphocyte culture experiments, revealed no upper limit to the dose-response curve; thus, in all experiments the undiluted antigen was employed. Phytohemagglutinin-P (PHA-P, Difco, Detroit, Mich.), reconstituted from the lyophilized state with tissue culture medium RPMI 1640 (Grand Island Biological Co., Grand Island, N.Y.), was stored at 4 C and renewed every 4 weeks. From (18) . Ten microliters of antigen suspension, or PHA-P, was added to appropriate tubes and incubation was carried out in 4% CO2 for 5 days at 37 C with a relative humidity of 85%. 1.0,uCi of thymidine-met/lyl-3H (3H-Tdr) with a specific activity of 1.9 Ci/mmole (Schwarz/Mann, Orangeburg, N.Y.) was added to each tube for the final 4 hr of incubation. After centrifugation at 800 X g for 10 min at 4 C, the supernatant medium was aspirated and the cell button was processed for determination of retained radioactivity in a liquid scintillation spectrometer (18) .
Serological methods. Complement-fixing (CF) antibodies in twofold dilutions of plasma were determined by a previously described micromethod (17) using the chloroform-methanol-extracted lipid antigen from M. pneumoniae (22) . Comparison of titers obtained with paired samples of serum and heparinized plasma showed no significant difference when specimens were handled as described above. (The addition of fresh heparin just before testing for CF antibodies did reduce the titers approximately fourfold; however, storage of plasma samples at 4 C or -20 C inactivated heparin as evidenced by formation of a fibrin clot upon thawing.) Growth-inhibiting (GI) antibodies were determined in a micromethod based on pH changes (phenol red) accompanying growth of serially diluted organisms during a 1-week period of incubation.
Units of growth inhibition represent the number of twofold organism dilutions showing no color change
in the presence of a constant amount of serum as compared to serum-free controls (16) . Computation of data. Multiple cultures were prepared from each donor sample to allow three or four replicate tests for each antigen and its paired control. Tubes which occasionally failed to show 3H-Tdr incorporation were disregarded. The arithmetic mean counts per minute of each set of determinations were converted to log10 for computation of group means and normal distribution since the cell populations tended to behave in a geometric fashion (18 ,Ten microliters of 1:10 dilution of stock phytohemagglutinin-P (PHA-P) (Difco). The difference between stimulated and unstimulated cultures in the control groups was negligible, whereas the difference for previously infected subjects was greater than eightfold. The mean stimulation indexes for the two groups differed by 0.751 log1o or a ratio of 5.6.
The data in Tables 1 and 2 are presented graphically in Fig. 1 . Based on the mean PHA response, ±2 standard deviations, a fivefold or greater stimulation index occurred with over 95 % frequency. Thirteen of the M. pneumoniae-immune cases responded to homotypic antigen within the PHA stimulation range. All of the 16 serologically positive cases showed a higher response than the serologically negative controls (P < 0.001, rank sum method). Thus, it was concluded that a threefold (0.5 log1o) or greater stimulation index for M. pneumoniae antigen was unlikely to occur in cultures of nonimmune cells and, therefore, this level of responsiveness was significant in this system. Correlation of M. pneumoniae serum antibody levels with peripheral lymphocyte culture response. In 34 separate peripheral lymphocyte culture (PLC) experiments, CF and GI antibodies were determined on the supernatant plasma. Subjects for these studies included those presented in the foregoing paragraphs and other volunteers whose history of exposure to M. pneumoniae had not been documented. Figure 2 illustrates the relationship of the GI Fig. 2. 0 or 1 unit of antibody, six had a threefold or greater stimulation index. These data revealed a high degree of correlation between the presence of serum antibody and the PLC response. However, the in vitro PLC method appeared to be more sensitive for detection of reactivity to M. pneumoniae than measurement of serum growth-inhibition capacity. As mentioned below, the tendency for specific lymphocyte reactivity to persist for several years also supports this observation. Figure 3 presents the relationship of CF antibody levels and lymphocyte responsiveness to M. pneumoniae in the same subjects. The large number of serological negatives responding in PLC and the scatter of all points indicate a poor correlation for this pair of tests compared with the previous figure. However, if time were added as a third dimension, nearly all CF-negative sera with significant PLC reactivity would be found in late convalescence. All but one person with a CF titer of 1:4 or greater responded in PLC; most, with 1:4 or greater titers, were studied in the first year of convalescence.
Duration of PLC response to M. pneumoniae.
The temporal relationships of antibody and cellular immune responses following infection are shown in Table 3 . Serologically negative subjects are presented in lieu of acutely ill patients. This was necessitated by the difficulty of identifying cases prior to development of pneumonia and the 7-day period required for cultivation of the etiological agent. Six young adults with proven infection and pneumonia were studied within 4 weeks of their first symptoms. All six had elevated CF and GI antibodies and five yielded a stimulation index greater than 3.0. Four of these subjects were restudied after 2 months and three, again, after 6 months. As indicated in the table, the level of antibody and PLC reactivity was generally sustained throughout this period of convalescence. Further followup was precluded by the academic calendar and accounts for the absence of observations beyond 6 months.
To determine the duration of these parameters of immunity following M. pneumzoniae pneumonia, subjects studied prior to development of the PLC method were contacted. Six persons, in whom infection had been documented 4 to 7 years previously, were found to have low or undetectable levels of one or both antibodies. Their PLC response, however, was in the same range as subjects studied during the first year after infection occurred. Nine volunteers, in whom the acute infection was undocumented, were presumed to be immune on the basis of elevation of at least one type of antibody. The lymphocyte response to M. pneumoniae antigen in these individuals also was in the range found during convalescence from documented disease.
DISCUSSION
In this study, M. pneunmoniae antigen stimulated tritiated-thymidine incorporation in cul- (30) , the gradual decline of titers in the present study suggests that this occurs infrequently. Further evidence of the rarity of reinfection is the paucity of documented cases (19) .
It has been proposed that M. pneumoniae disease is actually a secondary immune reaction, a preceding asymptomatic and, therefore, undetectable infection being required to sensitize the host (4). This concept was based on the finding of antibodies to M. pneumoniae by the highly sensitive complement-mediated killing test and a radioimmunoprecipitation method in subjects who lack evidence of specific immunity by conventional methods. The immunoprecipitin technique employed by Brunner et al. was based upon the complexing of labeled organisms with antibodies in human serum. Although there are several precipitable antigens in M. pneumoniae (21) , none of which have been related to biological activity in vivo, the significance of immunoprecipitin titers in human serum is unclear. Likewise, the complement-mediated killing test is of questionable biological significance, for antibodies can be found with this test in normal animals (21) . Thus, the increased sensitivity of these two methods may have been gained at the expense of specificity. Our data do not support the concept of M. pneumoniae disease as a hypersensitivity reaction. The course of experimental M. pnewnoniae infection (9, 12) , the correlation of the PLC response with natural infection, and its persistence for at least several years suggest that most persons experiencing M. pnewnoniae disease never before have been infected.
A subject of considerable interest at the present time is the development of M. pnewnoniae vaccines (5) . As in other superficial infections of the respiratory tract, immunity induced by natural disease or attenuated live vaccine is superior to that resulting from injection of killed organisms (14) . Although the highly specific GI 
